Disclaimer: This image is entirely AI-generated and is a product of artificial intelligence. Any resemblance to actual persons, whether living or deceased, is purely coincidental and unintentional.
Uploaded 1 month ago
Duration: 0h 6m 16s
Sun Pharma's Organon deal: Strategic entry into new segments, but integration challenges loom
Sun Pharmaceutical Industries' acquisition of US-based Organon & Co. for $11.75 billion, the largest overseas acquisition by an Indian pharma company, has been met with mixed reactions from brokerages, who see strategic entry into women's health and biosimilars but also flag potential integration challenges and debt concerns.
Uploaded by: Rediff Video Desk on Tue, 05 May 2026 16:04:00 +0530
Views: 27
Tags: Sun Pharma, Organon, Divyaxa Agnihotri of HDFC Securities, Merck, Bino Pathiparampil, Elara Securities, South Korea, China, Mehul Sheth, Established Brands
© 2026